These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32716081)

  • 1. A new cure rate model with flexible competing causes with applications to melanoma and transplantation data.
    Leão J; Bourguignon M; Gallardo DI; Rocha R; Tomazella V
    Stat Med; 2020 Oct; 39(24):3272-3284. PubMed ID: 32716081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cure rate survival model under a hybrid latent activation scheme.
    Borges P; Rodrigues J; Louzada F; Balakrishnan N
    Stat Methods Med Res; 2016 Apr; 25(2):838-56. PubMed ID: 23264557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On a class of non-linear transformation cure rate models.
    Balakrishnan N; Milienos FS
    Biom J; 2020 Sep; 62(5):1208-1222. PubMed ID: 32175632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
    Balakrishnan N; Pal S
    Stat Methods Med Res; 2016 Aug; 25(4):1535-63. PubMed ID: 23740876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the use of the modified power series family of distributions in a cure rate model context.
    Gallardo DI; Gómez YM; Gómez HW; de Castro M
    Stat Methods Med Res; 2020 Jul; 29(7):1831-1845. PubMed ID: 31559906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On a new piecewise regression model with cure rate: Diagnostics and application to medical data.
    Gómez YM; Gallardo DI; Leão J; Calsavara VF
    Stat Med; 2021 Dec; 40(29):6723-6742. PubMed ID: 34581460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A general class of promotion time cure rate models with a new biological interpretation.
    Gómez YM; Gallardo DI; Bourguignon M; Bertolli E; Calsavara VF
    Lifetime Data Anal; 2023 Jan; 29(1):66-86. PubMed ID: 36114312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vertical modeling: analysis of competing risks data with a cure fraction.
    Nicolaie MA; Taylor JMG; Legrand C
    Lifetime Data Anal; 2019 Jan; 25(1):1-25. PubMed ID: 29388073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective 3-parameter Gompertz model with frailty term for estimating cure fraction in survival data.
    Hajizadeh N; Baghestani AR; Pourhoseingholi MA; Khadem Maboudi AA
    J Biopharm Stat; 2023 Jan; 33(1):90-113. PubMed ID: 35671330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A flexible family of transformation cure rate models.
    Koutras MV; Milienos FS
    Stat Med; 2017 Jul; 36(16):2559-2575. PubMed ID: 28417477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family of Gamma-generated distributions: Statistical properties and applications.
    Pourreza H; Jamkhaneh EB; Deiri E
    Stat Methods Med Res; 2021 Aug; 30(8):1850-1873. PubMed ID: 34006148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mixed-effects regression model for the analysis of zero-modified hierarchical count data.
    Bertoli W; Conceição KS; Andrade MG; Louzada F
    Biom J; 2021 Jan; 63(1):81-104. PubMed ID: 33073871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Medical Data by Flexible Integer-Valued AR(1) Process with Zero-and-One-Inflated Geometric Innovations.
    Mohammadi Z; Sajjadnia Z; Sharafi M; Mamode Khan N
    Iran J Sci Technol Trans A Sci; 2022; 46(3):891-906. PubMed ID: 35645547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival models induced by zero-modified power series discrete frailty: Application with a melanoma data set.
    Molina KC; Calsavara VF; Tomazella VD; Milani EA
    Stat Methods Med Res; 2021 Aug; 30(8):1874-1889. PubMed ID: 33955295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified stochastic EM algorithm for cure rate model with negative binomial competing risks: An application to breast cancer data.
    Pal S
    Stat Med; 2021 Dec; 40(28):6387-6409. PubMed ID: 34783093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.